Search
-
NewAyming refuerza su actividad en España con una nueva sede en Bilbao
La compañía suma su nueva sede de Bilbao a su presencia en Madrid, Barcelona y Valencia
-
New3P Biopharmaceuticals nombra a Kenneth McMahon como Jefe de Control de Calidad
Se incorporará como apoyo a la dirección del departamento de control de calidad
-
NewAseBio joins the ShapingBio project to accelerate innovation in Europe's bioeconomy
The initiative, which includes entities from a dozen countries, aims to find responses to European climate priorities with bio-based products.
-
NewSchülke & Mayr GmbH acquires Spanish company Vesismin Health
Schülke & Mayr GmbH, a leading global provider in the fields of infection prevention and hygiene solutions in healthcare, acquires Vesismin Health, based in the Barcelona Science Park. The Spanish
-
NewConsituido el jurado de la III Edición de los Premios Zendal que galardonará a investigaci...
El jurado está formado por 5 expertos en el ámbito de la salud y dos directivos del grupo Zendal
-
New#NewMemberAseBio | "AseBio is the door to the networking with key relevant stakeholders in...
Meet MIMARK Diagnostics, S.L., our new member. We talked to Marina Rigau, CEO and founder of the company.
-
NewOnly 1 in 3 cancer patients protect their skin from the sun every day of the year
Some cancer therapies can affect the skin, making extra protection from the sun necessary during and after cancer treatment
-
NewBIOLAN revalidates its AOAC cetification for histamine quantification
BIOLAN renews the Performance Tested Method PTM AOAC 051604 certificate for the quantification of histamine concentration with the new BIOFISH 3000 HIS biosensor model
-
NewStandardized and Scalable: SphereFlash®, Automatic Colony Counter
SphereFlash®, IUL’s automatic colony counter, is the answer for laboratories that want to automate their colony count proces
-
NewSpecipig opens neonatal intensive care unit
Specipig has opened a neonatal intensive care unit (NICU) at its research facilities in the Barcelona area
-
NewBCN HEALTH publishes a study estimating the cost of thalassaemia care across the world
BCN HEALTH has published the study ‘Estimating the cost of thalassaemia care across the world: A Thalassaemia International Federation model’ in the journal ‘Hemoglobin’
-
NewMSD alcanza importantes avances en materia de ESG
MSD ha publicado su informe de 2021/2022 de avances en materia medioambiental, social y de gobernanza
-
NewLa inteligencia Artificial: Un reto para la Propiedad Intelectual
La Inteligencia Artificial está cambiando el mundo en el que vivimos y se encuentra presente en casi todos los sectores, la Propiedad Intelectual no es una excepción
-
NewADNTRO has been awarded as one of Europe's Top 10 Genomic Solutions providers in 2022
ADNTRO has been awarded as one of Europe's Top 10 Genomic Solutions providers in 2022, for standing out with its comprehensive domain expertise DNA studies and research focused on delivering consumer
-
New#NewMember | "AseBio has been a helping hand in gaining visibility and attracting resource...
Meet PALMEERA, our new partner. We talked to Jorge González Cánovas, the company's Operations Director.
-
NewBIOLAN awarded as "SME of the year of Bizkaia 2022" in the VI Edition of the SME of the ye...
The VI edition of the SME of the year awards was held in Bilbao on 18 July. These awards recognise essential aspects of the contribution to society and the economy of SMEs, which make up 99.8% of the
-
NewEl Ayuntamiento de Carboneras y Endesa testigos del avance de las obras de la planta de mi...
ALGAVILLAGE, proyecto conjunto de la compañía británica Firglas y la biotecnológica almeriense Biorizon Biotech, avanza firme con la construcción de su planta de microalgas en Carboneras (Almería)
-
NewORYZON reports results and corporate update for half-year ending June 30, 2022
Oryzon invests $8.1 million in R&D in the first half 2022
-
NewORYZON collaborates with the CMT Research Foundation in the US
To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth disease CMTRF to provide funding for in vivo efficacy tests in CMT preclinical model
-
NewGENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle t...
GENESIS Biomed will be the managing entity of the vehicle
-
Newpbserum enzymes continue to expand in the Middle East
This new launch follows a trend of expansion of the Spanish brand after its success in Europe and the Americas, with a significant presence in countries such as Mexico, Colombia and Argentina. Today